dalteparin has been researched along with Hemolytic-Uremic Syndrome in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saland, JM | 1 |
| Shneider, BL | 1 |
| Bromberg, JS | 1 |
| Shi, PA | 1 |
| Ward, SC | 1 |
| Magid, MS | 1 |
| Benchimol, C | 1 |
| Seikaly, MG | 1 |
| Emre, SH | 1 |
| Bresin, E | 1 |
| Remuzzi, G | 1 |
1 other study available for dalteparin and Hemolytic-Uremic Syndrome
| Article | Year |
|---|---|
Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome.
Topics: Anticoagulants; Child, Preschool; Complement Factor H; Enoxaparin; Hemolytic-Uremic Syndrome; Hetero | 2009 |